alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Fire Warden Roles and Responsibilities Training Feb. 14, 2018

/ Published Feb. 16, 2018
Richmond, Va., 
Defense Logistics Agency Distribution Richmond employees Janelle Shifflette, left, and Sabrina Bryant, middle; and Laray Deveaux, right, from Defense Contract Management Agency, all assigned as fire wardens for their work areas on Defense Supply Center Richmond, Virginia, simulate calling in a fire and using fire extinguishers while receiving instruction from Fire Inspector Daryhl Page, Fire and Emergency Services, DLA Installation Operations at Richmond.  The simulation took place during Fire Warden Roles and Responsibilities Training Feb. 14, 2018 in the McKeever Auditorium.  Training is provided quarterly by Fire and Emergency Services, and is part of their ongoing mission to train and educate the workforce.
#### ATLANTIC STEEL FABRICATORS, INC., Appellant, v. CONDOR SALES, INC., a Florida Corporation, Appellee.

No. 77-1008.

District Court of Appeal of Florida, Fourth District.

Feb. 14, 1978.

*165Robert D. Edwards of Atlantic Steel Fabricators, Inc., pro se.

No appearance for appellee.

DOWNEY, Judge.

This is an appeal from an adverse summary final judgment in favor of the appel-lee.

Appellee sued appellant to recover commissions allegedly due and attached an exhibit to the complaint which purported to represent appellant’s admission of the amount due. Appellant answered the complaint and denied any amount due and denied that the exhibit attached to appellee’s complaint was an admission of commissions due. Appellant also filed a counterclaim for damages which appellee denied.

Appellee then filed a motion for summary judgment and a supporting affidavit which in pertinent part stated that the exhibit attached to the complaint “is an identical copy of business records maintained by [appellant] during the normal course of their business, and indicates the amount of commission earned by Condor Sales, Inc./Robert De Lizza”. Appellant filed a counter-affidavit which stated the exhibit was not genuine; that it was not a record of commissions owed but of commissions projected or anticipated. The affidavit also asserted that appellant had been injured by appel-lee’s conduct causing appellant to lose work.

And so we have a routine, garden variety motion for summary judgment with affidavit . and counter-affidavit clearly demonstrating a genuine issue of fact both as to the complaint and as to the counterclaim. No reference whatsoever was made by ap-pellee to the counterclaim yet it too seems to have been eliminated by the summary final judgment.

Accordingly, the judgment appealed from is reversed and the cause is remanded for further proceedings.

REVERSED AND REMANDED.

DAUKSCH and MOORE, JJ., concur.
**Exhibit 21**

 

Subsidiaries

 
| **Name of  Subsidiary**               |   | **Jurisdiction  of Formation** |
|---------------------------------------|--------|--------------------------------|
|                                  |   |                           |
| Bio-Technology  General (Israel) Ltd. |   | Israel                         |
|                                  |   |                           |
| Myelos  Corporation                   |   | Delaware                       |
|                                  |   |                           |
| Acacia  Biopharma Limited             |   | United  Kingdom                |
|                                  |   |                           |
| Rosemont  Pharmaceuticals Limited     |   | United  Kingdom                |

 

1

----
----

**Exhibit      32.2**

**CERTIFICATIONS      OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT      TO 18 U.S.C. SECTION 1350, **
**AS      ADOPTED**

**PURSUANT      TO SECTION 906 OF SARBANES-OXLEY ACT OF 2002**

|   | 1. | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | To                my knowledge, the information contained in the Report fairly presents,                in                all material respects, the financial condition and results of operations                of the Company as of and for the period covered by the                Report. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  |  March                15, 2007 |   | By:    | /s/                David L. Young          |
|--------|-------------------------------------|--------|--------|--------------------------------------------|
|   |                                |   |   | David                L. Young,             |
|   |                                |   |   | Principal                Financial Officer |

----
ex102.htm


    
      Exhibit
        10.2

       

       

      Chinese/English
        Translation of Exhibit 10.1 - LongHua Biomass Energy Power Plant Project
        Investment and Construction Agreement dated October 10, 2007. 

      (Is
        attached as PDF reference)
* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be

published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

March 15, 2007

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-41478

Summary Calendar

UNITED STATES OF AMERICA,

PlaintiffAppellee,

versus

CESAR QUIROGA-RAMIREZ,

DefendantAppellant.

------------------------------------------------------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 7:04-CR-1054-1

-------------------------------------------------------------------

Before DeMOSS, STEWART and PRADO, Circuit Judges.

PER CURIAM:*

Cesar Quiroga-Ramirez (Quiroga) appeals the 70-month sentence he received following his

guilty-plea conviction for conspiracy to possess with intent to distribute more than 100 kilograms but

less than 1000 kilograms of marijuana. He contends that the district court erred in imposing a twolevel enhancement pursuant to U.S.S.G. § 3B1.1(c) based on a finding that he was a leader or

supervisor in the conspiracy. We have reviewed the record and determine that the district court did
-2-

not clearly err in imposing the enhancement. See United States v. Villanueva, 408 F.3d 193, 203 &

n.9 (5th Cir.), cert. denied, 126 S. Ct. 268 (2005); United States v. Ronning, 47 F.3d 710, 711 (5th

Cir. 1995).

Quiroga also assertsthat the district court erred in including 321 kilograms ofmarijuana found

at a stash house in the base offense level. He contends that the Government failed to prove beyond

a reasonable doubt that he engaged in a conspiracy involving those drugs. However, in light of

Quiroga’s guilty plea to a drug conspiracy, the Government was required to show at sentencing that

the marijuana at the stash house was “part of the same course of conduct or common scheme or plan

asthe offense of conviction.” U.S.S.G. § 1B1.3(a)(2). We have reviewed the record and determine

that the evidence in the presentence report is sufficient to warrant the finding of relevant conduct.

See United States v. Betancourt, 422 F.3d 240, 247 (5th Cir. 2005); United States v. De JesusBatres, 410 F.3d 154, 164 (5th Cir. 2005), cert. denied, 126 S. Ct. 1020 (2006). The judgment of

the district court is thus AFFIRMED.
Exhibit 23


                            CONSENT OF INDEPENDENT
                         CERTIFIED PUBLIC ACCOUNTANTS




    Tubby's, Inc. and Subsidiaries
    Sterling Heights, Michigan



    We hereby consent to the incorporation by reference in the Prospectus
    constituting a part of this Registration Statement (Form S-8) of our
    report dated February 3, 1998, relating to the consolidated financial
    statements of Tubby's, Inc. and Subsidiaries appearing in the Company's
    Annual Report on Form 10-KSB for the year ended November 30, 1997.





                                            BDO Seidman, LLP




    Troy, Michigan
    February 27, 1998




                                      37
Exhibit
        10.4

        

      
        11111
          Katy Freeway, Suite 910

        Houston,
          TX 77079

        (713)
          973-5720 tel

        (713
          973-5777 fax

        
 

      

      November
        9, 2007

      


      Mr.
        Ferdinando Petrucci

      Via
        Stazione, 133a

      Arce,
        Italy

      


      
        	Re:	
                Amendment
                  No. 4 (“Amendment No. 4) to the Exclusive License Agreement, dated March
                  20, 2006 and as amended September 11, 2006, December 13, 2006 and
                  November
                  3, 2007 between Ferdinando Petrucci (“Petrucci”) and H2Diesel, Inc.
                  (“H2”)  (as amended, the “License
                  Agreement”)

              


      

      


      Dear
        Mr.
        Petrucci:

      


      Please
        acknowledge your agreement that the License Agreement is further amended
        as
        follows, by executing this Amendment No. 4 to the License Agreement in the
        space
        provided below:

      


      	1.  	
              The
                due date for the US$1,500,000 payment required under section 1(b)(i)(C)
                of
                the License Agreement is extended from November 15 2007 to November
                29, 2007.

            


      


      	2.  	
              H2Diesel
                will pay Petrucci US$2,000,000 on or before November 29, 2007, with
                US$1,500,000 of such payment allocated to the payment formerly due
                on
                November 15, 2007 and US$500,000 of such payment allocated as a prepayment
                of the US$1,000,000 payment due on March 20, 2008 under section 1(b)(i)(D)
                of the License Agreement.

            


      


      	3.  	
              H2Diesel
                will pay Petrucci the remaining US$500,000 of the payment due in
                2008
                under section 1(b)(i)(D) of the License Agreement on February 20,
                2008.
                

            


      


      	4.  	
              H2Diesel
                will pay Petrucci the US$1,000,000 payment formerly due on March
                20, 2009
                under section 1(b)(i)(D) of the License Agreement on February 20,
                2009.

            


      


      	5.  	
              H2Diesel
                will pay Petrucci US$500,000 of the US$1,000,000 payment due in 2010
                under section 1(b)(i)(D) of the License Agreement on February 20,
                2010.

            


       

      Very
        truly yours,

      


      H2Diesel,
        Inc.

      
        	 	 
	By:  	/s/
                David A. Gillespie
	
                Name:
                  David A. Gillespie     

                Title:
                  President and Chief Executive Officer 

              


      

      


      Acknowledged
        and agreed as of the date above first written:

       

      
        
          	 /s/
                  Ferdinando Petrucci  
	
                  Ferdinando
                    Petrucci
SERVICE LIST

msinick@ssd.com carl.nelson@aa.com rpommer@atlasair.com sascha.vanderbellen@delta.com jeff.morgan@delta.com sametta.c.barnett@delta.com charters@evergreenairlines.com slachter@lachter-clements.com agoerlich@ggh-airlaw.com howard.kass@usairways.com benjamin.slocum@usairways.com jrichardson@johnlrichardson.com nssparks@fedex.com anbird@fedex.com david.heffernan@wilmerhale.com jeffrey.manley@united.com matwood@sherblackwell.com kevin.montgomery@polaraircargo.com dvaughan@kelleydrye.com mlbenge@zsrlaw.com bill@mietuslaw.com william.stallings@usdoj.gov dwight.moore@ustranscom.mil

12889958.1
[Federal Register Volume 62, Number 162 (Thursday, August 21, 1997)]
[Notices]
[Page 44479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22164]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute on Drug Abuse (NIDA) Special Emphasis Panel 
meetings:

    Purpose/Agenda: To evaluate and review contract proposals.
    Name of Committee: NIDA Special Emphasis Panel (Controlled 
Release Parenteral Delivery System of Buprenorphine).
    Date: August 18, 1997.
    Time: 1:30 p.m.
    Place: Office of Extramural Program Review, National Institute 
on Drug Abuse, NIH, 5600 Fishers Lane, Room 10-49, Rockville, MD 
20857 (Telephone Conference).
    Contact Person: Mr. Eric Zatman, Contract Review Specialist, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, Telephone 
(301) 443-1644.

    Name of Committee: NIDA Special Emphasis Panel (Preparation of 
Standardized Nicotine and Cigarettes for Addiction).
    Date: August 18, 1997.
    Time: 2:30 p.m.
    Place: Office of Extramural Program Review, National Institute 
on Drug Abuse, NIH, 5600 Fishers Lane, Room 10-49, Rockville, MD 
20857 (Telephone Conference).
    Contact Person: Mr. Eric Zatman, Contract Review Specialist, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, Telephone 
(301) 443-1644.

    This notice is being published less than 15 days prior to the 
meetings due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
    The meetings will be closed in accordance with provisions set forth 
in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Scientist Development, Research Scientist Development, 
and Research Scientist Awards; 93.278, Drug Abuse National Research 
Service Awards for Research Training; 93.279, Drug Abuse Research 
Programs, National Institutes of Health)

    Dated: August 13, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-22164 Filed 8-20-97; 8:45 am]
BILLING CODE 4140-01-M
----

|                              | /s/   Dennis      W.      Doll                   |   |
|-----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                              | Dennis      W. Doll                                                                                                                                  |   |
|                              | Chief      Executive Officer                                                                                                                         |   |
|                              |                                                                                                                                                 |   |
|                              |                                                                                                                                                 |   |
| Date:  May      6, 2008 |                                                                                                                                                 |   |

----
EXHIBIT 23
                                


                        Consent of Independent Auditors


We consent to the incorporation by reference in this Annual Report (Form 10-K)
of Commercial Properties 3, L.P. of our report dated February 3, 1997, included
in the 1996 Annual Report to Shareholders of Commercial Properties 3, L.P. and
Consolidated Ventures.

Our audit also included the financial statement schedule of Commercial
Properties 3, L.P. and Consolidated Ventures listed in Item 14(a).  This
schedule is the responsibility of the Partnership's management.  Our
responsibility is to express an opinion based on our audits.  In our opinion,
the financial statement schedule referred to above, when considered in relation
to the basic financial statements taken as a whole, presents fairly in all
material respects the information set forth herein.


                                                     ERNST & YOUNG  LLP

Boston, Massachusetts
February 3, 1997
PUBLIC LAW 110–426—OCT. 15, 2008 122 STAT. 4835 

Public Law 110–426 

110th Congress 

An Act 

To amend the Public Health Service Act to authorize increased Federal funding 

for the Organ Procurement and Transplantation Network. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Stephanie Tubbs Jones Organ 

Transplant Authorization Act of 2008’’. 

SEC. 2. INCREASED FUNDING FOR THE ORGAN PROCUREMENT AND 

TRANSPLANTATION NETWORK. 

Section 372(a) of the Public Health Service Act (42 U.S.C. 

274(a)) is amended by striking ‘‘$2,000,000’’ and inserting 

‘‘$7,000,000’’. 

SEC. 3. REPORT. 

(a) IN GENERAL.—The Secretary of Health and Human Services 

shall request that the Executive Director of the Organ Procurement 

and Transplantation Network submit to Congress, not later than 

1 year after the date of enactment of this Act, a report that shall 

include— 

(1) the identity of transplant programs that have become 

inactive or have closed since the heart allocation policy change 

of 2006; 

(2) the distance to the next closest operational heart transplant center from such inactivated or closed programs and 

an evaluation of whether or not access to care has been reduced 

to the population previously serviced by such inactive or closed 

program; 

(3) the number of patients with rural zip codes that received 

transplants after the heart allocation policy change of 2006 

as compared with the number of such patients that received 

such transplants prior to such heart allocation policy change; 

(4) a comparison of the number of transplants performed, 

the mortality rate for individuals on the transplant waiting 

lists, and the post-transplant survival rate nationally and by 

region prior to and after the heart allocation policy change 

of 2006; and 

(5) specifically with respect to allosensitized patients, a 

comparison of the number of heart transplants performed, the 

mortality rate for individuals on the heart transplant waiting 

lists, and the post heart transplant survival rate nationally 

and by region prior to and after the heart allocation policy 

change of 2006. 

42 USC 274 note. 

42 USC 201 note. 

Stephanie Tubbs 

Jones Organ 

Transplant 

Authorization 

Act of 2008. 

Oct. 15, 2008 

[H.R. 6469] 


kgrant on POHRRP4G1 with PUBLAW
122 STAT. 4836 PUBLIC LAW 110–426—OCT. 15, 2008 

LEGISLATIVE HISTORY—H.R. 6469: 

CONGRESSIONAL RECORD, Vol. 154 (2008): 

Sept. 23, 25, considered and passed House. 

Oct. 2, considered and passed Senate, amended. 

Oct. 3, House concurred in Senate amendment. 

Æ 

(b) LIMITATION ON FUNDING.—The increase provided for in the 

amendment made by section 2 shall not apply with respect to 

contracts entered into under section 372(a) of the Public Health 

Service Act (42 U.S.C. 274(a)) after the date that is 1 year after 

the date of enactment of this Act if the Executive Director of 

the Organ Procurement and Transplantation Network fails to 

submit the report under subsection (a). 

Approved October 15, 2008. 


kgrant on POHRRP4G1 with PUBLAW
Dolan Chemical Laboratory

4001 Bixby Road

Groveport, OH 43125

T: 614-836-4221, Audinet 210-4221

F: 614-836-4168, Audinet 210-4168

http://aepenv/labs

Water Analysis

Location: Mountaineer Plant Report Date: 5/25/2012

Form REP-702

Rev. 0, 4/2012

Sample Number: 122320-001 Date Collected: 05/23/2012 09:50 Date Received: 5/23/2012

Bioreactor Effluent 

Parameter Result Units RL MDL Analysis By Analysis Date/Time Method

Selenium, Se 0.7 ug/L 0.5 0.1 DPC 05/25/2012 13:40 EPA 200.8

Sample Number: 122320-002 Date Collected: 05/23/2012 09:50 Date Received: 5/23/2012

2nd Stage Feed 

Parameter Result Units RL MDL Analysis By Analysis Date/Time Method

Selenium, Se 2.5 ug/L 0.5 0.1 DPC 05/25/2012 13:44 EPA 200.8

Sample Number: 122320-003 Date Collected: 05/23/2012 09:50 Date Received: 5/23/2012

1st Stage Feed 

Parameter Result Units RL MDL Analysis By Analysis Date/Time Method

Selenium, Se 290 ug/L 0.5 0.1 DPC 05/25/2012 13:49 EPA 200.8

THIS TEST REPORT RELATES ONLY TO THE ITEMS TESTED AND SHALL NOT BE REPRODUCED EXCEPT IN FULL WITHOUT WRITTEN 

APPROVAL OF THE LABORATORY. ALL TEST RESULTS MEET ALL OF THE REQUIREMENTS OF THE ACCREDITING AUTHORITY, 

UNLESS OTHERWISE NOTED.

Brian Snyder, Chemist II

Email bssnyder@aep.com Tel. 614-836-4224

Fax 614-836-4168 Audinet 210-4224

Mountaineer Plant, 122320 Page 1 of 1
## F IFTH 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE O F 

## F LORIDA

_____________________________ Case No. 5D23- 0 682 LT Case No. 2 019

- CF-0 04942 -A

_____________________________ R EGINALD D ALE D AVIS , II, Appella nt,

v. S TATE OF F LORIDA , Appellee

.

_____________________________ On appeal from the Circuit Court for Duval County. Jeb Bra nham, Judg e. Matthew J. Metz, Public Def ender, and Andrew Mich, Assistant Public Defender, Daytona Beach, for Appellant. Reginald Dale Davis, II, Sneads, pro se. Ashley Moody, Attorney General, and Julian E. Markham, Assistant Attorney General, Tallahassee, for Appellee. February 27, 2024
P ER C URIAM
. A FFIRMED .
E DWARDS , C.J., and H ARRIS and P RATT , JJ., concur.2 _____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331 .

_____________________________